John Kinney

John Kinney is an accomplished executive in the pharmaceutical and life sciences sector, currently serving as the Chief Executive Officer of Validus Pharmaceuticals since June 2018, where responsibilities include aligning board strategy and enhancing profitability. Previously, Kinney led the North America Anti-Infective Business Unit at Sandoz from 2015 to 2018, developing strategic initiatives for product demand and supply coordination. Experience also includes serving as Advisory Director at PricewaterhouseCoopers LLC, where guidance was provided on commercial strategies for pharmaceutical and biotech companies, and Vice President of Marketing at Mylan, where a marketing organization was established for a $400 million business unit. Earlier roles at Genentech and Roche Pharmaceuticals contributed to expertise in product commercialization and strategic marketing. Academic qualifications include an MBA from NYU Stern School of Business, an MS from Seton Hall University, and a BS from Penn State University in Chemistry.